ACR Best Abstracts - Day 1 Save

The RheumNow faculty reporters have been glued to their monitors all day, viewing video, reading and listening to abstract presentations and I charged them to earmark those presentations were the “Best” they saw today. Below is the list of most often noted #ACRbest abstracts from Day 1.

• ACPA+ and subclinical synovitis does not automatically mean developing to RA, nor should  you use DMARDs. Interesting work by Cleo Rogier et al. Abstract #481

• Antiphopholipid Abs in COVID-19:  seen in 52% of hospitalized patients; Abstract #0429

• Newly discovered HGF & HGFAC genes differentiate PsA and PsO in genetic analysis.  Biomarkers for disease?  #ABS0500

• Is this The wave of the future?PsA smart phone measurement tools-  initial validation study.  #ABS0322

• QTc prolongation - not with hydroxychloroquine. Abstract #0431

• Guselklumab effective in PsA and PsO against other targeted therapies. #Abstract 0334    

• Dr Fernandez-Diaz on abatacept in RA-ILD in 263 patients. Abatacept appears safe and effective. Equivalent to RTX. Good option as s/c administration. Abstract #0233 

• Representation of Women as Authors of Rheumatology Research Articles. 41% of rheumatology workforce is women. 5 yr data-women underrepresented as senior authors, better parity in first authorship  #Abstract #0440